Please login to the form below

Not currently logged in
Email:
Password:

Ferring Pharmaceuticals promotes Aaron Graff

He takes up role as chief commercial officer and joins its executive board

Aaron GraffSwiss biopharmaceutical company Ferring Pharmaceuticals has promoted Aaron Graff to chief commercial officer and executive vice president.

He was previously CEO of Ferring’s US operations and in his new role he will also sit on the Saint-Prex-based firm’s executive board.

Graff first joined Ferring in 2002 as VP of global marketing, business development and medical affairs, based in Copenhagen.

After leading the acquisition and integration of Israeli biopharmaceutical company BTG in 2005, he relocated his team to the newly established Ferring International Center in Saint-Prex.

He was then made senior VP, Asia region and global marketing, and since 2010 has led Ferring’s stateside operations from its US headquarters in New Jersey, first as chief operating officer and since 2016 as CEO.

Michel Pettigrew, president of Ferring Pharmaceuticals’ executive board and chief operating officer, said: “Under Aaron’s leadership in the United States, our US business grew at double-digit rates. His broad, global professional experience and track record make him uniquely qualified for this important role.”

Prior to joining Ferring, Graff worked at Bristol-Myers Squibb for over 17 years in a variety of sales, marketing and commercial operations management positions.

2nd June 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics